Subscribe to the BioNews newsletter for free

Login
Advanced Search

Search for
BioNews

Like the Progress Educational Trust on Facebook


 


 

Stem cells safely transplanted into brains of patients with rare neurological disease

15 October 2012

By Joseph Jebelli

Appeared in BioNews 677

Scientists have successfully implanted human neural stem cells into the brains of children with a rare neurological disorder, called Pelizaeus-Merzbacher disease (PMD). People with PMD have severe deficits in speech and movement, and often do not survive to adolescence. PMD is an inherited condition, which leads to the loss of myelin, a fatty insulating substance that wraps around nerve cells to allow proper electrical signalling in the brain.

Researchers found that upon transplantation the stem cells developed into the main myelin-producing cells of the brain, called oligodendrocytes. 'For the first time, we have evidence that transplanted neural stem cells are able to produce new myelin in patients with a severe myelination disease', said Dr Nalin Gupta, lead author and associate professor of neurological surgery at the University of California, San Francisco (UCSF).

The phase I clinical trial was performed on the infants primarily to test safety, following promising findings in a mouse model of the disease. The neural stem cells, derived from donated fetal brain tissue by the biotechnology company Stem Cells, Inc, were surgically implanted into the brains of four boys with early-onset PMD.

One of the major concerns was whether or not the children would reject the cells, as the treatment did not use their own stem cells. Drugs were therefore used to suppress the children's immune systems and one year on the cells were still surviving. Neurological examinations were used to check the progress of the patients and magnetic resonance imaging (MRI) was used to detect the production of myelin.

'Without such studies in human patients, we won't really know how transplanted cells behave – whether they disperse or migrate, whether they engraft or degenerate and die, whether immune-suppressing regimens really work or not', said Dr Arnold Kriegstein, from the UCSF School of Medicine, who was not involved in the study.

The use of stem cells to effectively replace lost or dying cells has been a long sought-after goal in the treatment of a wide variety of brain disorders, including Alzheimer's disease, multiple sclerosis and stroke.

Dr Kriegstein remarked: 'It's only through these investigations that we will be able to refine the necessary procedures and technologies and make progress toward cell-based therapies for this disease and related disorders'.

The findings were published in the journal Science Translational Medicine.

SOURCES & REFERENCES
Science Translational Medicine | 10 October 2012
 
The Scientist | 10 October 2012
 
ScienceNOW | 10 October 2012
 
University of California, San Francisco (press release) | 10 October 2012
 

RELATED ARTICLES FROM THE BIONEWS ARCHIVE

19 August 2013 - by Dr Katie Howe 
A mouse heart was able to contract again after its own cells were removed and replaced with human stem cells, a study in Nature Communications reports...
03 June 2013 - by Nishat Hyder 
The Italian Senate has approved an 18-month, €3 million clinical trial of a controversial stem cell-based therapy. The vote, on 22 May 2013, will also allow a hospital to continue to treat twelve patients already undergoing the contested treatment...
13 May 2013 - by Dr Linda Wijlaars 
A genetic mutation responsible for both Sturge-Weber syndrome, a rare neurological disorder, and 'port-wine stain' birthmarks, has been identified...
11 February 2013 - by Richard Fadok 
Brain cells engineered from human skin tissue have successfully treated laboratory mice with a deadly nerve disorder with similarities to multiple sclerosis...
04 February 2013 - by Reuben Harwood 
Aged stem cells can be returned to a younger, more active state by increasing the activity of a single gene...

08 October 2012 - by Sarah Pritchard 
A team of Japanese researchers has created mouse eggs from stem cells and has fertilised them using IVF to produce baby mice. It is the first time scientists have reported producing properly functioning eggs using this type of stem cell....
08 October 2012 - by Antony Blackburn-Starza 
Professor Sir John Gurdon of the University of Cambridge has been jointly awarded the Nobel Prize for his work on stem cells. He shares the prize for medicine or physiology with Professor Shinya Yamanaka from Japan...
17 September 2012 - by Dr Greg Ball 
Stem cells have been used to partially restore hearing in deaf gerbils through replacement of their auditory nerve cells...
28 May 2012 - by Dr Lux Fatimathas 
A chemical produced by stem cells promotes recovery in mice with the autoimmune neurological disease, multiple sclerosis. Hepatocyte growth factor, which is produced by human mesenchymal stem cells, appeared to both repair existing damage and prevent future neurological harm in a mouse model of the disease...
28 September 2009 - by Dr Marianne Kennedy 
The US Food and Drug Administration (FDA) has granted approval to NeuralStem Inc., a Maryland-based biotherapeutics company, to conduct the first human trial using neural stem cells for treatment of amyotrophic lateral sclerosis (ALS). ALS is a type of motor neuron disease often referred to as 'Lou Gehrig's' and 'Maladie de Charcot'. The late-onset condition, of unknown cause, affects approximately two in 100,000 people, including the UK physicist Stephen Hawking and US rock gui...

HAVE YOUR SAY
Comment (lostkiwiboy - Updated on 15/10/2012)
I believe adult stem cell treatments are the way forward, as many trials dont even reach the end of stage 1 before the subjects are fully cured or at least show results which are generally not expected until the later part of stage 3 , also there is a lot less problems as they are using your own stem cells, not anyone else's. My Mother is 71, she lives in New Zealand, where she just had a adult stem cell transplant preformed only a few months a go, under the not for profit adult stemcell foundation org, she has been so impressed with the results that she learned how to start her own blog about it which has now morphed in to a full website with 'plain English' versions of the latest adult stem cell news, along with videos and explanations etc
www.stemcellpatient.net

You need to or  to add comments.

By posting a comment you agree to abide by the BioNews terms and conditions


- click here to enquire about using this story.

Published by the Progress Educational Trust

CROSSING FRONTIERS

Public Conference
London
8 December 2017

Speakers include

Professor Azim Surani

Professor Magdalena Zernicka-Goetz

Professor Robin Lovell-Badge

Sally Cheshire

Professor Guido Pennings

Katherine Littler

Professor Allan Pacey

Dr Sue Avery

Professor Richard Anderson

Dr Elizabeth Garner

Dr Andy Greenfield

Dr Anna Smajdor

Dr Henry Malter

Vivienne Parry

Dr Helen O'Neill

Dr César Palacios-González

Philippa Taylor

Fiona Fox

Sarah Norcross

Sandy Starr


BOOK HERE

Good Fundraising Code

Become a Friend of PET HERE and give the Progress Educational Trust a regular donation